MX9704738A - Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos. - Google Patents

Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos.

Info

Publication number
MX9704738A
MX9704738A MX9704738A MX9704738A MX9704738A MX 9704738 A MX9704738 A MX 9704738A MX 9704738 A MX9704738 A MX 9704738A MX 9704738 A MX9704738 A MX 9704738A MX 9704738 A MX9704738 A MX 9704738A
Authority
MX
Mexico
Prior art keywords
analogs
peptide
pharmaceutical compositions
same
compositions containing
Prior art date
Application number
MX9704738A
Other languages
English (en)
Spanish (es)
Inventor
Irun R Cohen
Dana Elias
Matityahu Fridkin
Original Assignee
Yenda Res And Dev Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9704738(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yenda Res And Dev Co Ltd filed Critical Yenda Res And Dev Co Ltd
Publication of MX9704738A publication Critical patent/MX9704738A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX9704738A 1994-12-21 1995-12-20 Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos. MX9704738A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
PCT/US1995/016596 WO1996019236A1 (en) 1994-12-21 1995-12-20 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES

Publications (1)

Publication Number Publication Date
MX9704738A true MX9704738A (es) 1997-10-31

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9704738A MX9704738A (es) 1994-12-21 1995-12-20 Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos.

Country Status (31)

Country Link
EP (1) EP0820303B1 (cg-RX-API-DMAC7.html)
JP (2) JP3420245B2 (cg-RX-API-DMAC7.html)
KR (1) KR100400480B1 (cg-RX-API-DMAC7.html)
CN (1) CN1233417C (cg-RX-API-DMAC7.html)
AR (1) AR002949A1 (cg-RX-API-DMAC7.html)
AT (1) ATE242005T1 (cg-RX-API-DMAC7.html)
AU (1) AU707835B2 (cg-RX-API-DMAC7.html)
BR (1) BR9510102A (cg-RX-API-DMAC7.html)
CA (1) CA2208274C (cg-RX-API-DMAC7.html)
CZ (1) CZ293784B6 (cg-RX-API-DMAC7.html)
DE (2) DE69531004T2 (cg-RX-API-DMAC7.html)
DK (1) DK0820303T3 (cg-RX-API-DMAC7.html)
ES (1) ES2201137T3 (cg-RX-API-DMAC7.html)
FI (1) FI118373B (cg-RX-API-DMAC7.html)
HR (1) HRP950612B1 (cg-RX-API-DMAC7.html)
HU (1) HU224160B1 (cg-RX-API-DMAC7.html)
IL (1) IL116499A0 (cg-RX-API-DMAC7.html)
IS (1) IS1966B (cg-RX-API-DMAC7.html)
MX (1) MX9704738A (cg-RX-API-DMAC7.html)
NO (1) NO317350B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ301440A (cg-RX-API-DMAC7.html)
PL (1) PL184145B1 (cg-RX-API-DMAC7.html)
PT (1) PT820303E (cg-RX-API-DMAC7.html)
RO (1) RO116777B1 (cg-RX-API-DMAC7.html)
RS (1) RS49517B (cg-RX-API-DMAC7.html)
SI (1) SI0820303T1 (cg-RX-API-DMAC7.html)
TR (1) TR199501630A2 (cg-RX-API-DMAC7.html)
TW (1) TW496872B (cg-RX-API-DMAC7.html)
UA (1) UA42040C2 (cg-RX-API-DMAC7.html)
UY (1) UY24130A1 (cg-RX-API-DMAC7.html)
WO (1) WO1996019236A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
WO1997043649A1 (en) * 1996-05-14 1997-11-20 Winnacker Ernst Ludwig CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
JP2005503320A (ja) * 2000-08-25 2005-02-03 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド ＣｐＧ−含有ポリヌクレオチドで自己免疫疾患を処置または防止する方法
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
EP2157101B1 (en) 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP peptides and analogs for modulation of immune responses via antigen presenting cells
WO2005072056A2 (en) 2004-01-28 2005-08-11 Develogen Israel Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
RU2282453C2 (ru) * 2004-12-14 2006-08-27 Александр Борисович Смолянинов Способ терапии больных сахарным диабетом ii типа
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
EP1858545A2 (en) 2005-03-04 2007-11-28 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
EA013821B1 (ru) 2005-05-25 2010-08-30 Кьюрдм, Инк. Проостровковые пептиды человека, их производные и аналоги и способы их применения
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
US8785400B2 (en) 2006-11-22 2014-07-22 Curedm Group Holdings, Llc Methods and compositions relating to islet cell neogenesis
EA201000399A1 (ru) 2007-08-30 2011-02-28 Кьюрдм, Инк. Композиции и способы использования проостровковых пептидов и их аналогов
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
CN104244967A (zh) 2012-03-01 2014-12-24 耶达研究与发展有限公司 用于抑制和治疗非自身免疫性糖尿病的Hsp60衍生肽和肽类似物
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
EP0820303A4 (cg-RX-API-DMAC7.html) 1998-03-11
DK0820303T3 (da) 2003-10-06
CN1233417C (zh) 2005-12-28
NZ301440A (en) 2000-01-28
AR002949A1 (es) 1998-05-27
KR100400480B1 (ko) 2003-12-31
CA2208274A1 (en) 1996-06-27
RS49517B (sr) 2006-10-27
CZ190897A3 (en) 1997-11-12
NO972849D0 (no) 1997-06-19
AU707835B2 (en) 1999-07-22
SI0820303T1 (en) 2003-10-31
CN1175214A (zh) 1998-03-04
UA42040C2 (uk) 2001-10-15
CZ293784B6 (cs) 2004-07-14
FI972669A0 (fi) 1997-06-19
TR199501630A2 (tr) 1996-07-21
JP3554319B2 (ja) 2004-08-18
NO972849L (no) 1997-08-13
TW496872B (en) 2002-08-01
HRP950612A2 (en) 1997-10-31
DE69531004D1 (de) 2003-07-10
DE69531004T2 (de) 2004-02-05
IS1966B (is) 2004-12-15
WO1996019236A1 (en) 1996-06-27
JP2004026797A (ja) 2004-01-29
BR9510102A (pt) 1997-11-25
NO317350B1 (no) 2004-10-18
HU224160B1 (hu) 2005-06-28
RO116777B1 (ro) 2001-06-29
JPH10511649A (ja) 1998-11-10
FI118373B (fi) 2007-10-31
PL321091A1 (en) 1997-11-24
DE820303T1 (de) 1999-05-20
ATE242005T1 (de) 2003-06-15
YU78795A (sh) 1998-05-15
PL184145B1 (pl) 2002-09-30
IL116499A0 (en) 1996-03-31
UY24130A1 (es) 1996-06-11
ES2201137T3 (es) 2004-03-16
EP0820303B1 (en) 2003-06-04
JP3420245B2 (ja) 2003-06-23
FI972669L (fi) 1997-08-15
HUT78092A (hu) 1999-09-28
EP0820303A1 (en) 1998-01-28
CA2208274C (en) 2005-12-06
IS4510A (is) 1997-06-19
PT820303E (pt) 2003-10-31
AU4686696A (en) 1996-07-10
HRP950612B1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
MX9704738A (es) Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos.
RU2214418C2 (ru) Аналоги glp-1
NO905472L (no) Insulinanaloger fra menneske og blandinger som inneholderdem.
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
EA200000872A1 (ru) Способы лечения диабета с помощью пептидных аналогов инсулина
MX9400190A (es) Derivados de tiazolidindiona, metodo para su obtencion y composicion farmaceutica que los contiene.
BR9714505A (pt) para o diabetes.
MD960317A (ro) Noile peptide-agoniste ale amilinei şi utilizarea lor
DK169784D0 (da) Peptider til farmaceutisk behandling af pattedyr
NO2000002I1 (no) Reteplase
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
DK0458064T3 (da) Stabilisering af somatotropiner ved modificering af cysteinrester
KR900003371A (ko) 재조합 천연 킬러 세포 활성화제
PT91468A (pt) Processo para a preparacao de um novo antibiotico mersacidina e de composicoes farmaceuticas que o contem
ES2087879T3 (es) Nuevos derivados de insulina, procedimiento para su preparacion, su uso y un preparado farmaceutico que los contiene.
ES2138973T3 (es) Muteinas de il-6 exentas de cisteina.
DE3884316D1 (de) Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung.
FI971427A0 (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
ES2144328T3 (es) Anticuerpo contra el profragmento de prorrenina, substancia con actividad de renina que contiene el mismo y ensayo de prorrenina que utiliza el mismo.
DE69534596D1 (de) Epil/plazentin
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
KR910007963A (ko) pST의 일부분에 대응하는 아미노산 서열을 갖는 펩티드, 그에 대한 항체 및 pST 활성에 효력을 더하는 방법